Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
doi: 10.1111/jcmm.14007 265 KimH
F.LiD.Toombs SmithS.RajiM
These symptoms occurred largely during the dose-escalation period, were transient and mild/moderate in severity, and led to drug discontinuation in up to 7% of participants in each active therapy group
The contribution of psychiatric AEs in GLP-1 RAs is not prominent compared with the background frequency of the SOC level, but with the dramatic increase in the number of GLP-1 RAs used, psychiatric AEs remain a notable proportion of the overall AEs associated with GLP-1 RAs ( Table 1 )
US$ 29.24
US$ 29.76
US$ 28.74
US$ 28.98
US$ 24.49
US$ 26.98
US$ 29.40
US$ 27.46
